Vikram Thermo India Ltd

Financial performance

• Q1 FY27 standalone unaudited: total income 3876.11 lakh; revenue from operations 3787.42 lakh.
• Profit after tax: Rs 1,328.16 lakh; EPS basic/diluted: Rs 4.24.
• Total expenses: Rs 2,086.03 lakh; cost of material consumed: Rs 1,213.50 lakh.
• Employee benefits expense: Rs 367.79 lakh; depreciation & amortization: Rs 87.99 lakh.
• Profit before tax: Rs 1,790.08 lakh.
• Single reportable segment: Pharma Polymers.
• Auditor's limited review conducted; board approved on 11 Aug 2026.
• Segment reporting not applicable as only Pharma Polymers segment exists.

Financial results

• Approved unaudited quarterly results for quarter ended 30 June 2026 with Limited Review Report.

AGM documents & book closure

• Approved draft Notice of 32nd AGM, Board's Report, Corporate Governance Report, and Secretarial Audit Report; book closure details.

Director reappointments

• Re-appointment of Ankur D Patel as WTD for five years from 13 Aug 2026, subject to shareholder approval.
• Re-appointment of Dineshkumar Patel as WTD for five years from 13 Aug 2026, subject to shareholder approval.

Related party disclosures

• Dineshkumar Patel is son of MD Dhirajlal Patel.

Cost Audit approval

• Approved Cost Audit Report for FY 2025-26.

Scrutinizer appointment

• Appointed M/s A Shah & Associates as AGM scrutinizer.

Dematerialisation status

• Securities received for dematerialisation were mutilated and cancelled; registered owner updated within the stipulated time.
• Securities dematerialised are listed on the stock exchanges where the earlier issues are listed.
• Securities received for dematerialisation up to the period were confirmed to the depositories.
• Physical certificates for dematerialisation were mutilated and cancelled; depository name substituted as registered owner within 15 days.

Financial Performance 📊

• Revenue from operations for Q3 FY26 was Rs 3,401.73 lakhs; total income was Rs 3,447.58 lakhs.
• Total income slightly declined from Rs 3,485.03 lakhs in Q2 FY26 to Rs 3,447.58 lakhs in Q3 FY26.
• Net profit before tax for Q3 FY26 was Rs 1,469.95 lakhs, marginally down from Rs 1,487.30 lakhs in Q2 FY26.
• Profit after tax for Q3 FY26 stood at Rs 1,096.22 lakhs, stable versus Rs 1,107.66 lakhs in Q2 FY26.
• Earnings per share for Q3 FY26 was Rs 3.50 basic and diluted, unchanged from previous quarter.
• Discontinued operations showed no profit or loss in Q3 FY26; prior year loss was Rs 2,566.03 lakhs.

Key Events & Risks ⚠️

• Exceptional loss of Rs 2,534.10 lakhs recognized in FY25 due to demerger of Aromatic Chemical unit.

Corporate Structure & Operations 📍

• Company operates in a single segment: Pharma Polymers.
• No subsidiary, associate, or joint venture as of December 31, 2025.

Governance & Audit 🗓️

• Board approved Q3 FY26 results on February 10, 2026; statutory auditors completed limited review with no qualifications.

Financial Performance 📊

• Approved unaudited financial results for the quarter ended 31 December 2025.
• Noted Limited Review Report by statutory auditor for the quarter ended 31 December 2025.